FRI371 Serum Androstenedione As An Additive Biomarker In Ectopic Cushing’s Syndrome Evaluation

Disclosure: S. Zhang: None. J.C. Lo: None. M.G. Jaffe: None. H. Arzumanyan: None. Background: Ectopic Cushing’s syndrome (ECS) results from glucocorticoid excess secondary to ectopic ACTH or CRH producing tumors. Although ECS identification can be challenging when presentation lacks classic Cushing’...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sherry, Lo, Joan C, Jaffe, Marc G, Arzumanyan, Hasmik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Neuroendocrinology And Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554263/
http://dx.doi.org/10.1210/jendso/bvad114.1303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554263/
http://dx.doi.org/10.1210/jendso/bvad114.1303

Ejemplares similares